title: [Ciliary epithelium and topical decongestants: how to minimize the undesirable events?].
abstract: The objective of the present study was to evaluate the influence of the combination of 0.1% xylometazoline with seawater (Rinomaris, "Jadran", Croatia) on the state and functional activity of the ciliary epithelium of the nasal cavity. The results of the study confirm the safety of this treatment and the possibility of its application in routine clinical practice.
authors.affiliation: Kafedra otorinolaringologii pediatricheskogo fakul'teta RNIMU im. N.I. Pirogova Minzdrava Rossii Moskva, Rossiia, 117997.
authors.forename: E L
authors.initials: EL
authors.lastname: Laberko
authors.affiliation: Kafedra otorinolaringologii pediatricheskogo fakul'teta RNIMU im. N.I. Pirogova Minzdrava Rossii Moskva, Rossiia, 117997.
authors.forename: N V
authors.initials: NV
authors.lastname: Zlobina
authors.affiliation: Kafedra otorinolaringologii pediatricheskogo fakul'teta RNIMU im. N.I. Pirogova Minzdrava Rossii Moskva, Rossiia, 117997.
authors.forename: E Yu
authors.initials: EY
authors.lastname: Radtsig
authors.affiliation: Kafedra otorinolaringologii pediatricheskogo fakul'teta RNIMU im. N.I. Pirogova Minzdrava Rossii Moskva, Rossiia, 117997.
authors.forename: M R
authors.initials: MR
authors.lastname: Bogomil'sky
mesh_terms: D000293:Adolescent; D002648:Child; D002923:Cilia / Q000187:drug effects*; D004338:Drug Combinations; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D009297:Nasal Mucosa / Q000187:drug effects*; D012623:Seawater / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D007093:Imidazoles; D014663:Nasal Decongestants; C009695:xylometazoline